2011 Ann Schreiber Grant Recipient – Gregory Motz
Gregory Motz, PhD
University of Pennsylvania
Stimulating Immune Cells to Fight Ovarian Cancer
Cancer vaccines, or treatments that enhance a patient’s immune system to fight tumor cells, hold great promise as a therapy for ovarian cancer. However, existing immunotherapies for ovarian cancer have been limited, highlighting the need for new approaches to achieve immunotherapy’s full potential for ovarian cancer. In Dr. Motz’s research, he aims to create special T-cells, or immune cells, that will be very effective in killing tumor cells. He will be working with a mouse model of ovarian cancer, but his findings could someday be applied to patient care.
Dr. Gregory Motz is a postdoctoral fellow in the laboratory of Dr. George Coukos at the University of Pennsylvania. He completed his doctoral thesis on the immune response in chronic obstructive pulmonary disease at the University of Cincinnati. He has since redirected his research interests to focus on the immune response in ovarian cancer. He is currently interested in cancer vaccines, barriers to anti-tumor immunity, and angiogenesis in tumor immunology.
This grant is supported in part by a generous donation from Teal There’s a Cure.
The five-year survival rate for ovarian cancer has increased by only 8% in the last 30 years.
We are at a critical crossroads for supporting research into unlocking the mysteries of ovarian cancer. You can make a difference by supporting the research of the Ovarian Cancer Research Fund.
Help us find a cure for ovarian cancer. Donate online and make a difference.